There is continuing debate about the natural history and management of optic nerve gliomas. Hoyt and Baghdassarian' and others2 ' have claimed that these tumours behave as hamartomas and that they should be managed conservatively. Others have reached different conclusions, stating that these tumours are not benign and self-limiting, and that treatment is required." In 1980 we reported on 17 patients and demonstrated a division into one group which was stable and another which showed active growth.5 One of these patients was subsequently found to have a meningioma, not a glioma as was first reported, and is described as case 1 in the accompanying paper.8 Since then we have seen a further 15 patients and they too have fallen into one of these two groups. We have adopted a radical surgical approach in those patients with evidence of active growth and without evidence of chiasmal involvement. In this paper we report our results and follow-up of 31 patients with this uncommon condition.
Patients and methods
Since 1973 we have seen 31 patients with an initial diagnosis of optic nerve glioma. The diagnosis was made on the basis of typical clinical and radiological findings, and in 16 patients in whom diagnostic tissue Correspondence to J E Wnght, FRCS, Moorfields Eye Hospital, City Road, London EC1V 2PD. was obtained our clinical diagnosis was confirmed histopathologically.
We have excluded the small number of older adults with the highly malignant form of optic glioma (glioblastoma), which usually involves the intracranial visual pathways and follows a quite different course. 9 A detailed clinical and family history was obtained and a full ocular and neurological examination performed in each patient. Visual fields were charted whenever possible, and most patients had pattern visual evoked potentials (VEP) recorded.
Patients were carefully examined for stigmata of von Recklinghausen's neurofibromatosis by the criteria of Crowe and Schull."' Plain skull films with optic canal views were routinely performed, and since 1975 all patients have had CT scans at presentation. In recent years most patients have also undergone magnetic resonance imaging (MRI).
The patients were assigned to two groups, (1) those with a 'stable' course and (2) those with 'active growth', on the basis of changes in vision and/or proptosis. A change was indicated by either the history (patient's or relatives' observations) or follow-up examination. For inclusion in the stable group our criteria were: (a) unchanged or improved vision, or vision worsening by less than 2 lines over a minimum period of two years, and (b) proptosis unchanged, decreasing or increasing by 2 
Results

CLINICAL FINDINGS
A total of 31 patients has been seen with a clinical diagnosis of optic nerve glioma. The details of their age and sex distribution are shown in Table 1 . The presenting symptoms are outlined in Table 2 and the physical findings in Table 3 . Fifteen of the 31 patients had neurofibromatosis (48%). All had reduced acuity at presentation, with 15 having 6/60 or worse vision (Table 4) . the average degree of proptosis was 3-0 mm, but six had no measurable proptosis whereas one was proptosed 8 mm. All but one patient had a relative afferent pupil defect, and this patient was found to have bilateral optic nerve involvement on CT but had presented with unilateral proptosis and visual failure. The ocular motility disturbance most commonly seen (14/31) was a limitation of elevation of the globe, which in many cases was quite marked.
RADIOLOGY
An enlarged optic foramen on plain x-ray was found in 25 patients at presentation. Twenty-six patients had CT scans at presentation (Fig. 1) (Figs. 2 and 3 ). In two patients it has detected chiasmal involvement when both CT and VEPs were normal. Fig. 2 Axial MRI of the same patient as in Fig. 1 presentation ranging from 2-2 to 38 years (mean 9 9 years, median 8 years), and at the onset of their symptoms from birth to 30 years (mean 5 9, median 3-5 years). Eleven of 16 had neurofibromatosis. In three patients in whom clinical examination suggested the glioma was confined to one optic nerve CT scans showed thickening of the contralateral nerve in two and the chiasm in the other. The optic disc was atrophic in 14/16 patients, with shunt vessels in one. Only two showed optic disc swelling, which was mild. Visual acuity improved spontaneously in three patients, one from 6/24 to 6/6 over seven years, and minor fluctuations in vision were common. Two patients also had a reduction in their proptosis of 2 and 3 mm in the period of followup. The greatest increase in proptosis was from 3 to 6 mm over six years. The remainder were unchanged or had increases of I or 2 mm over periods of two to 12 years. Follow-up has ranged from two to 13-5 years (mean 7-2, median 7-0 years). The exception was a patient with a one-month follow-up who presented at the age of 38 with a 27-year history of poor but stable vision and neurofibromatosis. Four patients within this group have been lost to follow-up after 2, 2-5, 3, and 8 years. Another patient within this group with neurofibromatosis and a five-year follow-up has a mother (not included in this series) with a chiasmal glioma that was irradiated and has remained essentially unchanged over at least 10 years.
Active group By contrast there were 15 patients with evidence of progressive enlargement of the tumour, eight added since 1980.1 These patients presented between the ages of 3-0 and 26-4 years (mean 10-7, median 9-0 years), and their symptoms began between birth and 26-0 years (mean 8-3, median 6-9 years). Only four of this group had neurofibromatosis. Nine had disc swelling, four optic atrophy, one had tumour on the disc, and another a total exudative retinal detachment.
Two patients from the 'active growth' group were confirmed as having chiasmal involvement by CT. One presented in 1974 ('patient 3's) with a fourmonths history of squint and two months' proptosis. During follow-up she developed visual evoked potential (VEP) evidence, and later visual field changes, indicative of chiasmal involvement. A CT in 1974 had failed to show chiasmal involvement but a later higher resolution scan detected it. The second patient presented first in 1973, ('patient 7'5) and during follow-up developed VEP and then perimetric evidence of chiasmal involvement. Only at this stage did a CT scan disclose an enlarged chiasm, and a pneumoencephalogram confirmed a suprasellar mass. A third patient's chiasmal disease was detected only on MRI.
Follow-up in the 'active growth' group has been from 1-5 to 14 years (mean 7-8, median 6-2 years). No patient has been lost to follow-up. One died after a pneumoencephalogram.
SURGERY
Ten patients with active growth without evidence of chiasmal disease were referred for neurosurgical exploration. Nine had a macroscopically normal chiasm and the optic nerve was therefore excised from the chiasm to the globe. The proximal end of the excised nerve was histologically clear of tumour in six patients and involved by tumour in three patients. One patient had an enlarged chiasm and the tumour was merely biopsied. A further patient had an orbital glioma excised through a lateral orbitotomy. Whether the tumour extended into the intracanalicular portion of the nerve is not known.
Three patients required enucleation. Deciding whether patients had an inactive or active lesion was usually straightforward. Most patients had an initial period of growth of the lesion with progressive proptosis. A minority of those with an inactive lesion had little or no proptosis at any stage, and poor vision was noted either accidentally or at routine school examination. The majority progressed to a period of quiescence, which we have observed to last a long as 13 years, with one patient reporting an interval of 27 years. Some while under observation experienced a reduction of proptosis and improved visual acuity. Active progressive gliomas continued to enlarge, with worsening vision and increasing proptosis usually accompanied by swelling of the optic disc and CT or MRI evidence ofgrowth of the tumour.
The frequency of disc swelling and restriction of ocular movement in patients with active lesions is probably due to enlargement of the tumour. Nine patients had disc oedema compared with only two in the inactive group, where optic atrophy was much more common (14/16) . Similarly, restriction of movement of the eye, usually limitation of elevation, was present in 11 patients with active growth, whereas only three patients with a stable course had any reduction of movement of the globe.
The most striking difference between the two groups was the higher incidence of neurofibromatosis in patients with a stable course (11/16) compared with those with active growth (4/15). The tendency for gliomas of the optic pathways, when associated with neurofibromatosis, to behave in an indolent manner has been noted previously."-'5 The overall incidence of neurofibromatosis in our patients was 48%. This is comparable to that observed in some other reports,'2 " but rates in other series have been lower (10}30%). 415 16 We have shown in this series that, while half of the optic nerve gliomas remained quiescent, the remainder enlarged. The crucial question is whether this enlargement is due to division of tumour astrocytes with spread along the optic nerve or is merely an increase in bulk caused by the accumulation of mucin or an associated desmoplastic reaction in the meninges. While the increase in the bulk of the tumour can be easily demonstrated with CT or even better with MRI,'7" it is extremely difficult to define the extent of the astrocytoma. The The difficulties in determining the natural history of these lesions was only partly due to our inability to assess their extent accurately. An even more important factor was our decision about eight years after the start of our study to excise the more rapidly growing and presumably more aggressive tumours.
During the early years of this study all patients were managed as though the gliomas would behave like a hamartoma. All 16 patients in the quiescent group have behaved in this manner, and none has developed evidence of invasion of the chiasm during quite long period of follow-up. Two of the first five patients with a more active course developed a contralateral field defect. One of these patients died during a pneumoencephalogram which was being carried out to determine the size of the chiasm. These events profoundly altered our attitude to the best way of dealing with these tumours. Subsequently additional evidence was provided by one of the patients in whom the optic nerve was excised, with microscopic tumour at the proximal cut end. This patient then developed a progressive field defect and enlargement of the contralateral optic nerve. We believe that these cases show that an optic nerve glioma does have the potential to expand within or extend into the chiasm in a similar manner to the case reported by McDonnell and Miller"2: an 11-year-old boy with an optic nerve glioma initially confined to the orbit and optic canal developed neuroradiological evidence of intracranial extension to involve the hypothalamus and third ventrical.
The results of surgical intervention have been instructive. One patient of the 10 who had a craniotomy had an enlarged chiasm, and the optic nerve was not excised. Three of the remainder had tumour at the proximal cut end of the nerve, making it probable that the chiasm was infiltrated by tumour even though it appeared normal to the surgeon. MRI, which was not used in any of these patients, may be capable of detecting small areas of involvement better than a surgeon using an operating microscope. None of our patients with normal MRI studies have had histological evidence of tumour in the chiasm, and two patients who had an enlarged chiasm with normal fields and CT scans were detected with MRI. It will be interesting to see to what extent MRI will enable us to select only those patients with an uninvolved chiasm.
There has been no evidence of tumour growth in either the chiasm or the contralateral optic nerve in any of the six patients where the glioma was totally excised during a follow-up period ranging from 2-10 years. In the three patients who had tumour up to the edge of excision, only one has shown an increase in the size of the chiasm with the development of an enlarged contralateral optic nerve associated with disc oedema and an abnormal field and VEP. The central vision has remained stable at 6/6 over seven years. The other two patients have shown no evidence of spread of their residual tumour over periods of six and nine years. This is in direct contrast to the activity and enlargement of the orbital portion of the tumour prior to craniotomy. Others have noted that incomplete removal of juvenile optic nerve gliomas does not necessarily lead to later clinical recurrence, and it has been suggested that removal of the main part of the tumour might remove the stimulus to its peripheral growth.'6 It could be argued that even patients with evidence of chiasmal involvement might benefit from removal of the optic nerve glioma, but we believe this approach is unjustifiable without more definite evidence. Further detailed follow-up of these patients will hopefully provide more evidence about the natural history and effect of treatment on this group of patients. In reviewing our patients over the last 15 years we have concluded that, while some gliomas are relatively inactive and may well have undergone the deceleration in growth which Alvord et al have suggested, others show a higher level of biological activity, with enlargement and worsening of the clinical picture. One cannot equate this growth of tumour with spread along the optic pathway, but there is sufficient evidence from our study and that of others to indicate that these tumours do pose a threat by direct extension of the astrocytoma into a previously uninvolved chiasm. This threat should be removed by total excision of the involved optic nerve particularly where vision is poor. We do not believe Patients with poor vision (6118 or worse) These patients should have a transfrontal exploration of the chiasm. If despite the normal investigations the chiasm is involved by glioma, further surgery is not indicated. In all other patients the optic nerve should be excised together with the tumour from just anterior to the chiasm to the posterior surface of the globe. If meningioma has spread into the middle fossa, the neurosurgeon will carry out a microsurgical removal of the tumour, if feasible, and possibly treat the area with postoperative radiotherapy. In occassional patients in whom the history suggests the tumour has been present unchanging for a number of years it may be reasonable to continue to observe the patient.
The accompanying flow chart (Fig. 4) indicates the salient points in our management of primary optic nerve tumours in young patients.
